Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRM01B in Acne Vulgaris
NCT02431052Phase 2Completed
- Sponsor
- Dermira, Inc.
- Start
- Apr 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of olumacostat glasaretil in acne vulgaris, sponsored by Dermira, Inc.. Started Apr 2015; status: completed.
02
Drugs
olumacostat glasaretil
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02431052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431052.